Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.72
0.02 (0.43%)
At close: Aug 15, 2025, 2:58 PM

Organogenesis Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
482.04M 433.14M 450.89M 468.06M
Cost of Revenue
115.74M 106.48M 105.02M 114.2M
Gross Profit
366.3M 326.66M 345.87M 353.86M
Operating Income
-1.28M 12.53M 22.3M 76.92M
Interest Income
n/a n/a 2.01M 7.24M
Pretax Income
-2.81M 10.39M 20.28M 63.09M
Net Income
861K 4.95M 15.53M 94.2M
Selling & General & Admin
294.51M 269.75M 283.81M 250.2M
Research & Development
50.27M 44.38M 39.76M 30.74M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
344.78M 314.13M 323.57M 280.94M
Interest Expense
1.54M 2.19M 2.01M 7.24M
Selling & Marketing Expenses
n/a 5.22M 4.81M 5.52M
Cost & Expenses
460.52M 420.62M 428.59M 395.14M
Income Tax Expense
-3.67M 5.45M 4.75M -31.12M
Shares Outstanding (Basic)
131.67M 131.23M 130.07M 128.33M
Shares Outstanding (Diluted)
131.67M 132.75M 132.38M 133.66M
EPS (Basic)
0.01 0.04 0.12 0.73
EPS (Diluted)
0.01 0.04 0.12 0.70
EBITDA
15.76M 36.03M 40.32M 87M
EBIT
-1.26M 12.58M 22.29M 70.32M
Depreciation & Amortization
17.03M 23.45M 18.03M 16.68M